The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of neoadjuvant trastuzumab, pyrotinib, and dalpiciclib without chemotherapy in early-stage HR-negative/HER2-positive breast cancer: An open-label, single-arm phase II trial.
 
Xiao Zhi
No Relationships to Disclose
 
Feiyu Chen
No Relationships to Disclose
 
Liqiu Liao
No Relationships to Disclose
 
Shayang Luo
No Relationships to Disclose
 
Xuan Liu
No Relationships to Disclose
 
Xiangyan Liu
No Relationships to Disclose
 
Tao Xu
No Relationships to Disclose
 
Yu Hu
No Relationships to Disclose
 
Na Luo
No Relationships to Disclose
 
Kuansong Wang
No Relationships to Disclose
 
Shouman Wang
No Relationships to Disclose